Should I sell my 3 favourite UK growth stocks and buy my 3 worst performers?

Harvey Jones is wondering whether to take the profits on his three most successful growth stocks, and plough the money back into his three biggest flops.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young woman holding up three fingers

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I buy FTSE growth shares with the aim of holding through thick and thin, to give them time to realise their full potential. But is this the right strategy?

Instead of buying and holding, a different school of thought suggests investors sell their winners every year or so, and reinvest their gains in some of their worst performers.

This works on the assumption that stock performance is cyclical. Successful stocks tend to be expensive, poor performers cheaper. Selling high and buying low is every investor’s dream, isn’t it?

Time to buy, hold or sell?

Also, success tends to come in waves. I’ve seen this with my three best performers over the last year: private equity specialist 3i Group, insurer Just Group and outsourcer Costain Group.

As my table shows, they’ve had a brilliant run lately. I also suspect they may struggle to maintain their momentum.


One monthOne yearTwo yearsFive years
3i Group5.87%64.54%183.04%198.04%
Just Group0.14%106.1%118.83%155.5%
Costain Group-2.87%80.6%153.75%-35.51%

My three worst performers have had a dismal few years.


One monthOne yearTwo yearsFive years
Burberry Group4.3%-64.22%-66.01 %-68.14%
Aston Martin-27.43%-58.47%-83.39%-96.94%
GSK-12.29%-1.84%9.87%-16.03%

The longest I’ve held any of these stocks is just 15 months. So luckily I haven’t lost 96.94% of my original stake, as I would have done if I’d bought Aston Martin Lagonda (LSE: AML) five years ago. At the same time, I’m not sitting on a 198.04% gain, as I would with 3i Group.

I only bought Aston Martin a month ago, and I’m already down 30%. I rarely put money into highly volatile stocks like this one. Basically, I had a small amount of cash left in my portfolio, and decided to have a flutter.

I knew what I was getting into. On 20 September I wrote that “Aston Martin makes sleek luxury cars but as an investment it’s been a wheezing old banger”, going bust seven times since it was set up in 1913.

Investing is a long-term game

I took a chance because the group is in transition mode, as it lines up its Vantage luxury supercar and upgraded DBX707 models. It had also just appointed a new CEO in Adrian Hallmark, fresh from a successful stint at Bentley Motors. I thought that might bode well. I was wrong.

On 30 September the board set it was likely to miss full-year targets, blaming supply chain delays and weak Chinese demand.

I’m certainly not selling any of my three winners to double down on Aston Martin. Shares in 3i Group, Just and Costain have idled in recent weeks, but I still see them as a better way to build long-term wealth.

I’m not buying more GSK either. Its short-term future rests on a string of US legal claims over discontinued heartburn medication Zantac. Before doing anything, I’ll wait for those to be settled. As for Burberry, I’ve thrown more than enough cash at that falling knife.

I think five of these six stocks will prove their worth over the longer run. Aston Martin is the wildcard. I shouldn’t have got involved, but don’t see much point selling now. So it’s still buy-and-hold all the way for me.

Harvey Jones has positions in 3i Group Plc, Aston Martin, Burberry Group Plc, Costain Group Plc, GSK, and Just Group Plc. The Motley Fool UK has recommended Burberry Group Plc and GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Santa Clara offices of NVIDIA
Investing Articles

Will Nvidia shares continue surging in 2026 and beyond?

2026 will be an exciting year for Nvidia shares as the semiconductor giant launches its latest generation of AI chips.…

Read more »

Investing Articles

Check out the BP share price and dividend forecast for 2026 – it’s hard to believe!

Harvey Jones is feeling rather glum about the BP share price but analysts reckon it's good to go. So who's…

Read more »

Investing Articles

I asked ChatGPT for its top FTSE 100 stock for 2026, and it said…

Muhammad Cheema asked ChatGPT for its top FTSE 100 pick, and its response surprised him. He thinks he’s found an…

Read more »

Investing Articles

By the end of 2026, can Rolls-Royce shares hit £17?

Rolls-Royce shares have had another phenomenal year, rising by 95.4%. Muhammad Cheema takes a look at whether they can continue…

Read more »

Investing Articles

Will Barclays shares continue their epic run into 2026 and beyond?

Noting that difference of opinion is a global norm, Zaven Boyrazian discusses what the experts think will happen to Barclays…

Read more »

Investing Articles

Prediction: analysts reckon Taylor Wimpey shares will soar almost 25% in 2026. Seriously?

When it comes to Taylor Wimpey shares, Harvey Jones is the eternal optimist. So will the high-yielding FTSE 250 housebuilder…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Up 83%+ last year, will these FTSE 100 shares do it all again in 2026?

These FTSE 100 stocks delivered share price gains of up to 403% over the last year! Royston Wild reckons they…

Read more »

Investing Articles

Could the Lloyds share price surge by 100% in 2026?

The Lloyds share price surged by almost 80% in 2025, making it one of the best-performing FTSE 100 stocks of…

Read more »